chrisvoncsefalvay/vaers-outcomes huggingface dataset:
both shots still itch and feels  scratchy  at  the injection sites; Headache; swollen right arm; itchy bumps; throat tightening,; blurry vision,; Runny nose; chest was hurting after the vaccination while she was at  the administration site; blood shot in patient's eye; blood pressure  was high; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of THROAT TIGHTNESS (throat tightening,), VISION BLURRED (blurry vision,), RHINORRHOEA (Runny nose), CHEST PAIN (chest was hurting after the vaccination while she was at  the administration site) and OCULAR HYPERAEMIA (blood shot in patient's eye) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetes. Concomitant products included BISOPROLOL FUMARATE, HYDROCHLOROTHIAZIDE (BISOPROLOL /HCTZ) for an unknown indication.    On 11-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced THROAT TIGHTNESS (throat tightening,), VISION BLURRED (blurry vision,), RHINORRHOEA (Runny nose), CHEST PAIN (chest was hurting after the vaccination while she was at  the administration site), OCULAR HYPERAEMIA (blood shot in patient's eye) and HYPERTENSION (blood pressure  was high). On 13-Mar-2021, the patient experienced PERIPHERAL SWELLING (swollen right arm) and RASH PRURITIC (itchy bumps). On an unknown date, the patient experienced VACCINATION SITE PRURITUS (both shots still itch and feels  scratchy  at  the injection sites) and HEADACHE (Headache). The patient was treated with EPINEPHRINE (EPIPEN) on 11-Mar-2021 for Adverse event, at an unspecified dose and frequency and NAPROXEN SODIUM (ALEVE) for Headache, at an unspecified dose and frequency. At the time of the report, THROAT TIGHTNESS (throat tightening,), VISION BLURRED (blurry vision,), RHINORRHOEA (Runny nose), CHEST PAIN (chest was hurting after the vaccination while she was at  the administration site), OCULAR HYPERAEMIA (blood shot in patient's eye), PERIPHERAL SWELLING (swollen right arm), RASH PRURITIC (itchy bumps) and HEADACHE (Headache) outcome was unknown, HYPERTENSION (blood pressure  was high) had resolved and VACCINATION SITE PRURITUS (both shots still itch and feels  scratchy  at  the injection sites) had not resolved.            Concomitant medications taken were Diabetes medications (Unspecified name).   Treatment medications were Steroid Shot (NOS).      This case was linked to MOD-2021-037564 (Patient Link).
At 12 hours post administration awoke with chills and mild rigors which progressed to feeling feverish and full body aches and uterine aching.  Fatigue, poor appetite and flu like symptoms persisted for 18 hours and was in bed for the day.  Unable to lift arm or lie on arm on injection side for 24 hours. Missed day of work.   18 weeks pregnant at the time.
Child received vaccines around 10:45 am and left office around 11:00 am. Within minutes from leaving the office, around 11:15 am the child developed hives on face, ears and neck. Mom gave BENADRYL and called nurse triage line. Child was scheduled for office evaluation at 12:30 pm. Presented in office with resolving urticaria/ wheals. DX with allergic urticaria. No further treatment given.
LEFT ARM - INJECTION SITE - PAIN, SWELLING,  REDNESS, ITCHY & LYMPH NODES UNDER ARMPIT ENLARGED. FEVER, CHILLS, SWEATS, BODY ACHES, FATIGUE, HEADACHE, NECK PAIN & STIFFNESS SYMPTOMS STARTED 5PM ON 2/13/21 & STILL HAVE SYMPTOMS AS OF 2/16/21 (1ST DOSE ONLY)
Immediately after finishing a lunch meal on 2-14-21, I blacked out, without warning,  and fell from my chair to the floor. I remained unconscious for approximately 30 seconds. My blood pressure reading was 136/82 approximately 10 minutes after the incident. This apparent vagal syncope was the first I have experienced. Had I been operating a motor vehicle, I would have crashed the vehicle as the blackout was instantaneous. I visited my PCP on 2-17-21. He checked my blood pressure and performed an EKG and both were normal. He has requested appointments with a cardiologist and a neurologist.
patient admits to vagal response and passing out in past. few mins after vaccine became diaphoretic and near syncopal. arrived to obs and placed in tredelenberg, bp 119/80 hr 58 rr 18 sats 98% on ra. offered snack and water, refused snack. few mins later, diaphoresis resolved. stretcher sat up, bp 123/78 hr 50 rr 18 sats 98% on ra; states baseline is bradycardic around 50's. sat up to side of bed with feet dangling, bp 116/81 hr 52, then 112/80 hr 58, then standing bp 104/70 hr 63, patient started to feel dizzy and needed to lie back down, once laying down bp returned to 123/81 hr 50. 5 mins later, sitting bp 118/81 hr 53, standing 111/75 hr 58, few mins of standing had bp 90/63 hr 57, tingling in fingers and dizziness, causing patient to need to lay back down. few mins later lying bp 109/69 hr 59 sitting bp 113/70, 114/79, 121/86. standing bp checks 121/87, 114/82, and stabilized with final bp at 117/83. no further s/s of issues or orthostatic hotn. escorted with spouse, who was driving, to exit with no issues.
severe local cellulitis-like rxn;worse on 16MAY96 than initially & getting worse;empiric ATB tx;
Presented to the ED on 10/30/2019  with worsening SOB, generalized weakness, and purple rash on bilateral upper and lower extremities and tachycardia.   Pt reports the only change in the past week was the fact that she had the influenza vaccination administered on Thursday 10/24/2019  and  she noticed the rash on Saturday  10/26/2019.  Starting Tuesday 10/29/2019 she noticed dyspnea on exertion and some shortness of breath at rest.  Pt denies any new medications, insect bites or recent illness.  PE was ruled per CT.   Admitting diagnosis is Hemolytic anemia and tachycardia.
The injection site reaction was an inch or two away from actual injection site. There was an red streak 1" wide and 4" in length and it lasted about 10 days but had no pain.  I had the Pneumonia Vaccine vaccine 10 years earlier.
30 mins after injection in left arm - numbness progressing up left side into neck and face and also down the left side of body.
This spontaneous report as received from a physician (it was also reported the primary reporter was the patient's mother) refers to a 17 year old female patient with asthma. The patient had no drug reactions or allergies. On 29-JUL-2013 the patient was vaccinated with the first dose of GARDASIL (lot number, dose, route and injection site were not reported). Concomitant therapies included XOPENEX Inhaler (dosage unspecified). On 29-JUL-2013 developed a fever of 104 and joint pains and chills and weakness and asthma attacks and then broke out in hives. She went to the emergency room for a few hours for medical attention and was treated (treatment unspecified) and the hives went away. A week later (on 05-AUG-2013) the hives returned and the mother gave the patient BENADRYL and the hives subsided. A few days later (approximately in August 2013) they came back again and the patient still had hives. The patient did not plan to continue with the series. Treatment BENADRYL was given for adverse events. There was no lab diagnostics study performed. Therapy with GARDASIL was discontinued. The outcome was reported as not recovered/not resolved. Additional information has been requested.
No other adverse event; Unknown number of administrations of VARIVAX following a temperature excursion; This spontaneous report was received from a licensed practical nurse and refers to unknown number of patients of unknown age and gender. The patients' concurrent conditions, drug reaction or allergies, pertinent medical history and concomitant therapies were not reported.    On an unknown date, the patients were vaccinated with an improperly store doses of varicella virus vaccine live (OKA/MERCK) (VARIVAX) for prophylaxis (dose, lot #, expiration date and route were not reported) (product storage error). No other adverse events and nor product quality complain were reported.  This is a non-valid case due to lack of patients' identifiers.  Follow-up information has been received from licensed practical nurse on 23-OCT-2023, referring to a 4-years-old male patient. Current conditions included allergic rhinitis.  On 25-SEP-2023, the patient was vaccinated with an improperly store doses of varicella virus vaccine live (OKA/MERCK) (VARIVAX) valid lot W034707, expiration date: 01-NOV-2024, subcutaneously for prophylaxis (dose and route were not reported) (Product storage error). Temperature excursion occurred as result of reading Digital Data Logger. Temperature was out of range as +5 Fahrenheit (F) (also reported as +7 F) for 10 minutes.  This is one of two reports from the same reporter.
At annual exam, Dr. noted the following:  1. Breast lump in left breast - follow-up: diagnostic mammo/ultrasound on 7/2 at Breast Center on left breast only - Dr. determined it was cyst. -Annual bilateral screening mammo on 7/9 - Dr. noted mass in left breast and has ordered another diagnostic mammo/possible ultrasound on left breast for 7/15  2. Possible enlarged right ovary - follow-up; pelvic ultrasound on 6/30 showed normal ovaries and endometrium, but 5.5 cm fibroid extending from right fundus of uterus. Dr. advised expectant management with hope that fibroid shrinks as I go through menopause.  3. Dr. advised complete blood work with my primary care Dr.  6/28? -  CBC, CMP, Rheumatoid Factor, Thyroid and Sed rate - all in normal range
This spontaneous report was received from a nurse referring to a 15 month-old patient of unknown gender. The patient's pertinent medical history, drug reactions/allergies, concurrent conditions and concomitant medications were not reported. On 13-NOV-2017, the patient was vaccinated with a dose of M-M-R II lot # M049212 with expiration date 16-DEC-2018, for prophylaxis (dose and route of administration were not reported). Other suspect therapies included sterile diluent (MERCK) lot # N006807 with expiration date 31-JUL-2019. It was stated that at the time of vaccination, "more than half of the vaccine dripped out onto the patient's leg". No adverse effects were reported.
Muscle Atrophy, size of a quarter at injection site; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE ATROPHY (Muscle Atrophy, size of a quarter at injection site) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced MUSCLE ATROPHY (Muscle Atrophy, size of a quarter at injection site). At the time of the report, MUSCLE ATROPHY (Muscle Atrophy, size of a quarter at injection site) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
A report has been received from a Health Professional concerning a subject of unknown gender, who had been receiving FLUMIST QUADRIVALENT.  FLUMIST QUADRIVALENT started on an unknown date. It was reported that at pediatrician office they had some FLUMIST QUADRIVALENT that had frozen . Some of the FLUMIST had been administered to about 250 patients. The outcome of the event of frozen FLUMIST QUADRIVALENT and frozen FLUMIST QUADRIVALENT was administered to about 250 patients is unknown. The report was considered to be non-serious.
Patient is past due for dose two of Shingrix; This case was reported by a other health professional via call center representative and described the occurrence of incomplete course of vaccination in a 85-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on 23rd May 2018., batch number-ZY3X4 and expiration date-1st April 2019).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. Till the time of reporting, patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination.
feels like he has a cold; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A male patient received bnt162b2 (BNT162B2), administration date 11Feb2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: NASOPHARYNGITIS (non-serious), outcome "unknown", described as "feels like he has a cold". Additional information: It was reported that the patient was scheduled for second dose on 04Mar2021 and he missed the second dose. He was inquiring if he can get the vaccine so far apart.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Injection site pain; headache; muscle pain; chills; joint pain; nausea; feeling unwell; sore throat; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6204) via unspecified route of administration in right arm on 16Mar2021 at 09:45 (at the age of 52-years-old), as a single dose for COVID-19 immunisation. Medical history included high blood pressure, obesity and heart palpitations. Prior to vaccination, the patient was not diagnosed with COVID-19. The concomitant medication included irbesartan (MANUFACTURER UNKNOWN), hydrochlorothiazide (MANUFACTURER UNKNOWN) and acetylsalicylic acid (ASPIRIN), from unspecified dates for unknown indications. The patient had no known allergies. The patient experienced vaccination site pain, headache, muscle pain, chills, joint pain, nausea, feeling unwell and sore throat on 17Mar2021 at 09:00. Post vaccination, the patient underwent Nasal Swab test for COVID-19 on 19Mar2021 and the result was pending. It was unknown if the patient received any treatment for vaccination site pain, headache, muscle pain, chills, joint pain, nausea, feeling unwell and sore throat. The adverse events resulted in Doctor or other healthcare professional office/clinic visit. The clinical outcome of vaccination site pain, headache, muscle pain, chills, joint pain, nausea, feeling unwell and sore throat was recovering.   No follow-up attempts are needed. No further information is expected.
COVID 19; COVID 19; This is a spontaneous report received from a contactable reporter(s) (Physician). The reporter is the patient.  A 51-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 26Dec2020 as dose 1, single (Lot number: EL0142), on 06Jan2021 as dose 2, single (Lot number: EL3302) and on 06Oct2021 as dose 3 (booster),single (Lot number: 301558A) at the age of 51 years for covid-19 immunisation; coviD-19 vaccine mrna (mrna 1273) (COVID-19 VACCINE MODERNA), on 06May2022 as dose 4 (booster), single (Lot number: 056M21A) for covid-19 immunisation. The patient's relevant medical history included: "known allergies: penicillins" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) positive, notes: COVID 19 Treatment; (17Jul2022) Negative; (21Jul2022) positive, notes: re-tested positive for COVID. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: No Other medication in 2weeks. vaccine was received. Anti-viral details product was for COVID 19 Treatment, Brand=pfizer, Treatment start date was 11Jul2022 and stop date was 16Jul2022. Adverse event Rebound symptoms (sore throat, runny nose) and re-tested positive for COVID. This occurred 5 days after patient's last dose of Paxlovid and 4 days after patient had tested negative. No AE treatment was received.; Sender's Comments: Based on the information available a possible contributory role of the suspect BNT162B2 cannot be excluded for the reported events of drug ineffective, covid-19.
Patient had about 4 days of Head pressure, weak legs, balance issues, arm numbness and had trouble clasping or closing his hands. Patient says he is ok now.
after the 2nd vaccine dose at 1000am i statred to get chills and fvere of 100.2 at 6oopm. After self medicating with Motrin and Nyquil fever went down to 99.6 by the time i woke up at 600am on January 21 2021 but i still had the chills. On January 22 2021 at 600am all symptoms' was gone with a temp of 97.5.
Within 10 hours of shot: Chills Body aches Fever up to 103.6
This spontaneous report as received from a nurse refers to an unspecified number of patients of unknown age and gender. The nurse reported that, on an unknown date, an unspecified amount of doses of PROQUAD 0.5 ml, subcutaneous (lot # and expiration date were not reported) that underwent a temperature excursion was administered to an unspecified amount of patients. No adverse effect was reported. Follow up information was obtain during a telephone call to the licensed practical nurse, on 23-JAN-2015. The licensed practical nurse did not have lot numbers and expiration dates readily available for PROQUAD, and reported that no adverse event had been reported following administration of vaccinations. Follow up information has been received from the licensed practical nurse on 18-MAR-2015, concerning a currently 5 years old patient of unknown gender, who was vaccinated with PROQUAD lot number K009894, expiration date not reported. This is one of several reports from the same reporter. Additional information is not expected, since all the information needed to complete the case has been received.
Initial misuse report received from a healthcare professional on 10 January 2014. A 06-month-old patient (gender unknown) had received a dose of PENTACEL on an unspecified date. It was reported that the patient received only DTaP IPV without ACT-HIB portion. No adverse event was reported. List of documents held by sender: none.
Headache and chills started around 7:30pm on 06-Apr-2021 (about 8 hours after injection). Headache worsened so I took 2 Tylenol pills. The next morning, the chills were gone, though I felt slightly feverish and headache still remained. I took another 2 Tylenol and by 12pm on 07-Apr-2021, all symptoms were resolved and I felt ok. I've continued to feel ok since.
Patient was given a 2 pediatric doses of the peds moderna monovalent -0.5ml, instead of the adult moderna bivalent-0.5ml.
Information has been received from a 74 year old female registered nurse with no allergies and a history of hip replacement, 2 TIA (transient ischaemic attack) in 1989 and chickenpox as a child who on 18-JUN-2008 was vaccinated with ZOSTAVAX (Merck) (lot# not reported). Concomitant therapy included PLAVIX, LIPITOR, BENICAR, baby ASPIRIN, calcium (unspecified), cranberry pill twice a day and multivitamins (unspecified). On 24-APR-2009 the nurse thought she had a bug bite on the back of the neck that was itchy. This "bug bite" spread across the shoulders and down the right arm but not all the way. On 25-APR-2009 the nurse noticed her right eye was getting red so she used CLEAR EYES but it didn't get any better. On 04-MAY-2009 the nurse was diagnosed with shingles. The nurse reported that the area of "bug bite" was still burning and itching and her right eye was still red. The nurse sought medical attention by phone call and office visit. The nurse took 2 ALEVE and the physician prescribed "FAMCICLOVIR 50mg 3 times daily and generic ELAVIL 10mg for sleep". No lab diagnostic studies were performed. At the time of the report, on 04-MAY-2009, the nurse had not recovered from the shingles. The reporting nurse considered shingles to be disabling as her neck was very stiff. Additional information has been requested.
Sore arm at the injection site; whole body and muscle aches; fever of 101 degrees; whole body feels warm; nausea; fatigue and sleeping more than usual.  Symptoms started at 4 AM the following morning, gave him some Tylenol to bring down the fever, and have him drinking lots of ice water.  He has no appetite because he feels nauseous but he was able to eat a piece of bread which seemed to settle his stomach somewhat.
On Sunday night I started feeling achy and tired. On Monday I woke up with no voice and that night I started having fever, chills, and bad cough. I went to the doctor where I work, and they prescribed me promethazine-dm which did nothing for the cough. On Tuesday I had a stuffing head and running nose. I had no voice for a week straight. I also took Sudafed and that did not work either. So, I called my doctor, and she prescribed Amoxicillin. Two days later I started to feel better but then I woke up with pink eye.
Patient came in to the pharmacy complaining of a sore arm (she expected) but redness and swelling around the injection site. Patient showed me the area and it was pink and raised. She was advised to make sure the site didnt get any worse and to treat with ibuprofen.
PT received two doses of PCV13 in a week, initial dose on 7/24/10 second on 7/31/2010.  No symptoms reported by parents.
Went on an 8-day Cruise 12/18/22-12/26/22.  Began to experience early symptoms on 12/27/22.  Tested  with home COVID test which was negative on 12/27,   Tested again on 12/28 which was positive.  Symptoms developed into cough, oral mucosa pain, general malaise, low-grade fever, tiredness.  Called PCP's office and was placed on  antiviral (not Paxlovid, the one that starts with O).  Symptoms improved by 1/8 but still tested positive.  Finally tested negative on 1/15/23.
Developed redness, swelling locally in Rt. deltoid where administered. Systemic chills without fever, myalgias.
Pt came to hospital after falling sustaining faracture, pt underwent orif. pt tested positive at discharg, pt discharge home.
Pt. RTC on 10/18/12 for MMR #2 to meet college requirement. States after MMR on 8/28/12 had high fever and increased HR next day. States sx's had resolved by end of day. Dr order to hold MMR #2.
Patient was present in the clinic on 7/21/2022 for his 2nd dose of Moderna (6 months ? 5yrs formulation, lot number As1414B). RN, the vaccinator, went ahead to vaccinate on the left vastus lateralis. RN's arm moved back, and the needle left the injection site prior to vaccine administration (needle plunger has not been pressed).  Vaccinator and parent were able to witness that none of the dose enter the site. RN was able to assess the site for any scratching or bruising as well assessed for any bleeding. RN notified the Charge nurse,.  Parent received education on the need for repeating dose on different site (right vastus lateralis) per our protocol since none of the dose had entered the site. The parent was educated on watching the child for any bruising and that the child can be given Tylenol for comfort. Parent expressed understanding and consented to re-administration of dose in opposite site. Client was able to successfully receive dose.